Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV single-arm multicenter study of Lingze tablet for benign prostatic hyperplasia
ChiCTR2000033201Phase 4Recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jan 2017
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Lingze in benign prostatic hyperplasia (BPH), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: International Prostate Symptom Score and Curative effect of TCM syndrome. Started Jan 2017; status: recruiting.
02
Drugs
Lingze
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on ChiCTR2000033201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033201.